Vigil Neuroscience Inc (VIGL)
3.52
-0.02
(-0.56%)
USD |
NASDAQ |
May 17, 16:00
3.52
0.00 (0.00%)
After-Hours: 20:00
Vigil Neuroscience Total Assets (Quarterly): 125.08M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 125.08M |
December 31, 2023 | 140.86M |
September 30, 2023 | 159.16M |
June 30, 2023 | 175.41M |
March 31, 2023 | 192.36M |
December 31, 2022 | 200.39M |
Date | Value |
---|---|
September 30, 2022 | 215.51M |
June 30, 2022 | 157.93M |
March 31, 2022 | 172.81M |
December 31, 2021 | 102.44M |
September 30, 2021 | 114.42M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
102.44M
Minimum
Dec 2021
215.51M
Maximum
Sep 2022
159.67M
Average
159.16M
Median
Sep 2023
Total Assets (Quarterly) Benchmarks
TG Therapeutics Inc | 373.32M |
Terns Pharmaceuticals Inc | 246.77M |
NovaBay Pharmaceuticals Inc | 5.357M |
Palatin Technologies Inc | 11.41M |
iBio Inc | 34.02M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 21.30M |
Shareholders Equity (Quarterly) | 103.78M |